Keep up to date with the latest media releases from the department.
It is positive that people have heard the message and are taking action to get vaccinated against influenza. Record numbers of seasonal influenza vaccines have been brought into the country this year.
An independent expert health panel established by the Australian Government has concluded there is mostly limited or in some cases no evidence, that human exposure to per- and poly-fluoroalkyl substances (PFAS) is linked with human disease.
Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.
The Department of Health welcomes the Information Commissioner’s final report following his investigation into the department’s release of a sample of data from the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS).
Australia’s Chief Medical Officer, Professor Brendan Murphy, has announced that a Voluntary Blood Testing Program for people impacted by PFAS contamination from RAAF Base Tindal in Katherine will begin on Saturday 17 March.
The best medical advice and research shows that codeine is no better for pain than other over the counter medicines, Australia’s Chief Medical Officer, Professor Brendan Murphy, said today.
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.